It’s spooky season, but some of the scariest stories aren’t found in haunted houses. They’re hiding in pharmacy benefit contracts.
From mysterious pricing to disappearing savings, traditional PBM practices can leave employers facing some frightening surprises. Here are four PBM horror stories every plan sponsor should watch out for.
The Zombie Contract: The Agreement That Won’t Die
Some PBM contracts seem impossible to escape, even when performance and service fall short of expectations. Restrictive terms, automatic renewals, and limited termination rights can leave employers trapped in a partnership that’s no longer delivering value.
The scary truth: A contract should protect your plan, not hold it hostage.
Frankenstein Pricing: A Monster of Hidden Costs
Spread pricing, confusing definitions, and hidden fees can create a pricing model that’s been stitched together in all the wrong ways. What looks like a good deal on paper can quickly turn into a monster of unpredictable costs.
The scary truth: If you can’t clearly see how your PBM makes money, you may be paying more than you think.
Vampire Rebates: Sucking the Life Out of Savings
Rebates can look impressive, but are they delivering real value? When rebate arrangements prioritize high-list-price drugs or allow PBMs to retain manufacturer compensation, employers may be left in the dark about their actual savings.
The scary truth: Big rebates don’t always mean lower net costs.
Trick-or-Treat Formularies: What’s Behind the Next Door?
One day a medication is covered. The next, it’s not. Formulary changes driven by financial incentives rather than independent clinical decisions can create confusion, disruption, and unexpected costs for members.
The scary truth: Formulary decisions should prioritize clinical appropriateness and lowest net cost, not hidden financial incentives.
Time to Put PBM Nightmares to Rest
Your pharmacy benefit shouldn’t come with tricks, surprises, or monsters hiding in the fine print.
Employers can avoid these PBM nightmares by looking for a partner that offers clear contract terms, full visibility into pricing and rebates, independent audit rights, and measurable savings. Add independent clinical oversight and a commitment to the lowest net cost, and there’s no reason to fear what’s lurking behind the numbers.
At SlateRx, we believe in a PBM partnership built on transparency, accountability, independent clinical oversight, and measurable savings. No smoke and mirrors. No scary surprises.
Spooky tricks are out. Real partnership is in.
Ready to leave the PBM nightmares behind? Contact us to learn more.
